The European Medicines Agency said Friday it has been asked by the European Commission to conduct a review of certain arthritis drugs following the worldwide withdrawal of Merck amp; Co.'s Vioxx medication.
The Food and Drug Administration told Merck amp; Co. that it requires further safety and efficacy data before it will approve its successor drug to now defunct pain reliever Vioxx, the pharmaceutical maker announced Friday.
That's because Arcoxia is Merck's successor drug to Vioxx, which was taken off the market last month after a study showed patients taking it had double the rate of heart attacks and strokes
